# Post-Market Real-World Evidence Registry for the NeuroOne OneRF® Ablation System for Epilepsy

> **NCT07546253** · — · NOT_YET_RECRUITING · sponsor: **NeuroOne Medical Technologies Corporation** · enrollment: 100 (estimated)

## Conditions studied

- Drug Resistant Epilepsy
- Refractory Epilepsy

## Interventions

- **OTHER:** Participants are not assigned an intervention as part of the study.

## Key facts

- **NCT ID:** NCT07546253
- **Lead sponsor:** NeuroOne Medical Technologies Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2028-07
- **Final completion:** 2028-07
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07546253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07546253, "Post-Market Real-World Evidence Registry for the NeuroOne OneRF® Ablation System for Epilepsy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07546253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*